C1-Esterase Inhibitor (Recombinant) and Empagliflozin and linagliptin
Determining the interaction of C1-Esterase Inhibitor (Recombinant) and Empagliflozin and linagliptin and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: C1 esterase inhibitor (human)
Brand name: Berinert, Cinryze, Haegarda, Ruconest
Synonyms: Complement C1 esterase inhibitor, C1 Inhibitor (Human)
Generic Name: empagliflozin / linagliptin
Brand name: Glyxambi
Synonyms: Empagliflozin and Linagliptin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- C1-Esterase Inhibitor (Recombinant)-Empagliflozin and metformin
- C1-Esterase Inhibitor (Recombinant)-Empagliflozin and Metformin Extended-Release Tablets
- C1-Esterase Inhibitor (Recombinant)-Empagliflozin and Metformin Tablets
- C1-Esterase Inhibitor (Recombinant)-Empliciti
- C1-Esterase Inhibitor (Recombinant)-Emsam
- C1-Esterase Inhibitor (Recombinant)-Emsam Transdermal
- Empagliflozin and linagliptin-Cabazitaxel
- Empagliflozin and linagliptin-Cabazitaxel Intravenous
- Empagliflozin and linagliptin-Cabergoline
- Empagliflozin and linagliptin-Cablivi
- Empagliflozin and linagliptin-Cabometyx
- Empagliflozin and linagliptin-Cabozantinib